More articles about: Rogel Cancer Center

Danielle Schuldt was diagnosed with a rare endocrine tumor and underwent surgery as part of her treatment. She now undergoes regular surveillance to monitor for cancer recurrence.

University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.

U-M researchers developed a new strategy to improve immunotherapy treatments for pancreatic cancer.

At Taylor Street Primary Care Clinic, improving colorectal cancer screening rates isn’t about checking a box, it’s about meeting patients where they are.

Katrina Studvent shares her experience from breast cancer to patient to advocate.

In early 2026, Rachel Bergmans, Ph.D., MPH, was named as administrative director of the COE team. We sat down to get to know her better and what her goals are in her new role.

Using one's cells to attack and treat cancer continues to grow. Cellular therapy and in particular CAR T-cell therapy offers new opportunities to adult and pediatric patients with blood cancers like leukemia and lymphoma. Dr. Monalisa Ghosh, Rogel Cancer Center oncologist talks about these treatments and and the future of cellular therapy.

Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.

A pancreas cancer surgeon explains from Michigan Medicine how to find the best place for treatment, why that matters, and what to expect from the process.

Andrew Sweeney was diagnosed with stage 4 colorectal cancer at age 31 and underwent a liver transplant, chemotherapy and radiation treatment.

University of Michigan researchers found that the FDA-approved drug fedratinib can lead to endoplasmic reticulum and mitochondria contact site formation, providing a potential therapeutic avenue.

University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.

University of Michigan researchers have demonstrated that donated ovarian tissue can produce natural hormone cycles in mice, with the aim of restoring female hormone cycles for pediatric cancer survivors.

Josephine “JoJo” Wells, a spontaneous triplet, was diagnosed with rare hepatoblastoma at nine months old and treated with surgery and chemotherapy.

There has been little progress in understanding and treating liposarcoma due to its rarity and lack of research resources. In a new study, University of Michigan researchers have developed a novel mouse model that mirrors the disease in humans.